ARIA Sustained Viral Resilience
Funds United Kingdom teams improving viral resilience through sustained health and technology research.
ARIA Sustained Viral Resilience sits under the Advanced Research and Invention Agency's Sculpting Innate Immunity opportunity space and funds work on antiviral resilience and immune engineering. The programme is designed for for-profit R&D performers, including UK and international teams, and it focuses on research that can alter how hosts resist viral threat rather than on routine therapeutic development. Awards run from about £250,000 to £3 million, with a median award of £1 million. The call is annual, the TRL window is 2 to 5, and non-profits and individuals are not eligible. The programme does not ask for matched funding, and prior participation in the same solicitation is a disqualifier rather than a positive signal. Applicants are best placed when the proposal is tightly scoped around an immune-engineering mechanism with a believable experimental path. ARIA's funding style here favors teams that can turn a biological hypothesis into a hard R&D plan with clear milestones, not groups that need a long discovery runway before any technical readout appears.
No upcoming rounds verified. Cadence: Annual.